Dawn McCullough
Nurse Practitioner · Green Bay, WINPI 1144858713
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $48.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Sanofi$642
- United Therapeutics Corporation$415
- Jazz Pharmaceuticals Inc.$355
- Baxter Healthcare$345
- Actelion Pharmaceuticals US, Inc.$306
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,91896%
- Education$2244%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 16 | $1,168 |
| Sanofi | 8 | $642 |
| United Therapeutics Corporation | 8 | $415 |
| Jazz Pharmaceuticals Inc. | 15 | $355 |
| Baxter Healthcare | 4 | $345 |
| Actelion Pharmaceuticals US, Inc. | 4 | $306 |
| Amgen | 3 | $304 |
| GSK | 12 | $238 |
| Inspire Medical Systems, Inc. | 7 | $232 |
| Regeneron Healthcare Solutions, Inc. | 2 | $204 |
| Boehringer Ingelheim | 3 | $186 |
| Grifols USA, LLC | 3 | $146 |
| Johnson & Johnson | 1 | $98 |
| Inogen, Inc. | 4 | $84 |
| AbbVie | 3 | $81 |
| Verona Pharma, Inc. | 3 | $79 |
| Sanofi-aventis U.S. LLC | 1 | $62 |
| Merck | 1 | $49 |
| Insmed, Inc. | 3 | $47 |
| Electromed, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $23 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,141 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 123 | $103,622 |
| Spiriva RespimatTiotropium Bromide | 79 | $56,718 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 71 | $45,870 |
| Spiriva HandihalerTiotropium Bromide | 40 | $26,651 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 44 | $25,476 |
| Breo ElliptaFluticasone/Vilanterol | 41 | $23,142 |
| SymbicortBudesonide/Formoterol Fumarate | 75 | $22,646 |
| Advair HfaFluticasone Propion/Salmeterol | 37 | $21,233 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $15,330 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 21 | $13,441 |
| Incruse ElliptaUmeclidinium Bromide | 22 | $13,386 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 56 | $12,605 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 35 | $8,875 |
| Atrovent HfaIpratropium Bromide | 15 | $7,268 |
| Arnuity ElliptaFluticasone Furoate | 19 | $5,764 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $238 | $171,390249 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $186 | $116,029171 claims |
| AstraZenecaSymbicort, Breztri Aerosphere | $1,168 | $37,976100 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Other nurse practitioner in Green Bay
- Sally BowaGreen Bay$117K
- Vicki FresenGreen Bay$16K
- Vicki Hutterer TrostGreen Bay$5K
- Sarah BurtonGreen Bay$5K
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Nicole BarteltWaukesha$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.